CNVE authorizes AstraZeneca Covid-19 vaccines in Costa Rica

San José, Apr 9 (Prensa Latina) The National Vaccination and Epidemiology Commission (CNVE) approved the use of AstraZeneca anti-Covid-19 vaccine in Costa Rica for people over 18 years but not pregnant or breastfeeding women.

April 9, 2021
08:16

Before the arrival of the first batch of 43,200 doses, from the agreement signed by Costa Rica with the Covax mechanism, Health Minister Daniel Salas announced that the CNVE would wait for the analysis of the European Medicines Agency (EMA) to confirm its application.

National Coordinator of Immunizations and Influenza of the Ministry of Health Roberto Arroba said that the AstraZeneca vaccine relation with blood clots is extremely rare (6.5 cases per million vaccinated people).

In this way, the AstraZeneca vaccine will be applied in people over 18 years, except pregnant and breastfeeding women, he said, while confirming that the vaccine scheme is to apply two doses in 12 weeks between each one.

ef/pll/jf/ale